HMPL-760 Safety and Tolerability Study in Patients With Previously Treated CLL/SLL or NHL

Clinical trial NCT05176691 · WITHDRAWN

Trial details

NCT number: NCT05176691
Sponsor: Hutchmed
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

CLL/SLL NHL MCL MZL Lymphoplasmacytic Lymphoma Waldenstrom Macroglobulinemia Follicular Lymphoma DLBCL Richter Syndrome

Start date: 2022-02-15
Primary completion: 2022-11-16
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.